Acme United Corporation Recalls Med-Nap Cleansing Towelettes Due to CGMP Deviations

Source: FDA · United States

Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.

Acme United Corporation has issued a voluntary recall for several lots of Med-Nap Cleansing Towelettes distributed nationwide due to manufacturing practice deviations.

What this FDA recall tells you, and what most readers miss

This notice was issued by FDA on April 2, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.

Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.

Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, OTC-drug.

What Happened

Acme United Corporation has initiated a voluntary recall of Med-Nap Cleansing Towelettes (Benzalkonium Chloride 0.13%). The recall, classified as a Class II event by the FDA, was prompted by Current Good Manufacturing Practice (CGMP) deviations. The firm began the recall process on January 20, 2026, after identifying issues that did not meet regulatory manufacturing standards.

Which Products Are Affected

The recall affects the following products distributed nationwide within the United States:

  • Product Name: Med-Nap Cleansing Towelettes (Benzalkonium Chloride 0.13%)
  • Packaging: 100 Towelettes per box
  • NDC Number: 0924-0243-01
  • UPC: 0092265940375
  • Lot Numbers: 52347, 52348, 52349, 52350, 52351
  • Expiration Date: March 2027
  • Recall Number: D-0371-2026

What You Should Do

Consumers and healthcare providers who have the affected lots of Med-Nap Cleansing Towelettes should immediately stop using the product. Acme United Corporation initiated the notification process via letter. For information regarding product returns or further inquiries, consumers may contact Acme United Corporation at their headquarters located at 1 Waterview Dr Ste 200, Shelton, CT 06484.

Why This Matters

This recall is significant because Current Good Manufacturing Practice (CGMP) deviations indicate that the product may not have been manufactured under the rigorous quality and safety standards required by the FDA for over-the-counter drug products.

Source

Information provided by the U.S. Food and Drug Administration (FDA).

Original source: FDA Official Notice ↗

All FDA Recalls →

Frequently Asked Questions

Common questions about this FDA recall.

What is this FDA recall about?
Acme United Corporation has issued a voluntary recall for several lots of Med-Nap Cleansing Towelettes distributed nationwide due to manufacturing practice deviations.
Which agency issued this alert?
This alert was issued by FDA. The original notice is available at the source link at the bottom of this article.
How severe is this alert?
This alert is classified as "medium" severity. Stay informed and follow agency guidance.
What area is affected?
This alert affects United States. Check with FDA for the most current geographic scope.
Where can I find more FDA Recalls updates?
Browse the full FDA Recalls feed on Areazine at areazine.com/recalls/fda/ for the latest updates from FDA and other agencies.